118 related articles for article (PubMed ID: 35488907)
1. No impact of time to treatment initiation for head and neck cancer in a tertiary university center in 2003, 2008 and 2013.
Kouka M; Engelhardt M; Wittig A; Schultze-Mosgau S; Ernst T; Guntinas-Lichius O
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4549-4560. PubMed ID: 35488907
[TBL] [Abstract][Full Text] [Related]
2. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
3. Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study.
Jensen JS; Jakobsen KK; Mirian C; Ghanizada M; Håkansson K; Wessel I; Grønhøj C; Rasmussen JH; von Buchwald C
Acta Oncol; 2021 Apr; 60(4):491-496. PubMed ID: 33356698
[TBL] [Abstract][Full Text] [Related]
4. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
[TBL] [Abstract][Full Text] [Related]
5. Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort.
Frank MH; van Dijk BAC; Schoonbeek RC; Zindler J; Devriese LA; van Es RJJ; Merkx MAW; de Bree R
Radiother Oncol; 2024 Mar; 192():110107. PubMed ID: 38262531
[TBL] [Abstract][Full Text] [Related]
6. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma.
Balchander D; Shorbaji K; Cabrera CI; Hoying D; Clancy K; Fowler N; Thuener JE; Lavertu P; Pan Q; Teknos TN; Rezaee RP; Li S; Tamaki A
Am J Otolaryngol; 2023; 44(6):103966. PubMed ID: 37481899
[TBL] [Abstract][Full Text] [Related]
8. Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.
Gbolahan O; Hashemi-Sadraei N; Yash S; Williams G; Ramachandran R; Kim YI; Paluri R; Outlaw D; El-Rayes B; Nabell L
Cancer Med; 2023 Feb; 12(3):3488-3498. PubMed ID: 35979540
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population.
Sheni R; Qin J; Viswanathan S; Castellucci E; Kalnicki S; Mehta V
JCO Oncol Pract; 2023 Jun; 19(6):e904-e915. PubMed ID: 37001038
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
11. The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.
Polesel J; Furlan C; Birri S; Giacomarra V; Vaccher E; Grando G; Gobitti C; Navarria F; Schioppa O; Minatel E; Bidoli E; Barzan L; Franchin G
Oral Oncol; 2017 Apr; 67():175-182. PubMed ID: 28351574
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
Cushman TR; Jones B; Akhavan D; Rusthoven CG; Verma V; Salgia R; Sedrak M; Massarelli E; Welsh JW; Amini A
Clin Lung Cancer; 2021 Jan; 22(1):e84-e97. PubMed ID: 33039348
[TBL] [Abstract][Full Text] [Related]
13. Predictors of time to definitive surgery and survival in Merkel cell carcinoma: analysis of the US National Cancer Database.
Desai AD; Behbahani S; Samie FH
Clin Exp Dermatol; 2022 Jul; 47(7):1275-1282. PubMed ID: 35150153
[TBL] [Abstract][Full Text] [Related]
14. Time to treatment initiation and survival in adult localized, high-grade soft tissue sarcoma.
Featherall J; Curtis GL; Lawrenz JM; Jin Y; George J; Scott J; Shah C; Shepard D; Rubin BP; Nystrom LM; Mesko NW
J Surg Oncol; 2019 Dec; 120(7):1241-1251. PubMed ID: 31587292
[TBL] [Abstract][Full Text] [Related]
15. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
16. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
[TBL] [Abstract][Full Text] [Related]
17. Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database.
Yusuf M; Gaskins J; Tennant P; Bumpous J; Dunlap N
Pract Radiat Oncol; 2019; 9(4):e372-e385. PubMed ID: 30926480
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy.
Cadoni G; Giraldi L; Petrelli L; Pandolfini M; Giuliani M; Paludetti G; Pastorino R; Leoncini E; Arzani D; Almadori G; Boccia S
Acta Otorhinolaryngol Ital; 2017 Dec; 37(6):458-466. PubMed ID: 28663597
[TBL] [Abstract][Full Text] [Related]
20. Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
J Nucl Med; 2014 Sep; 55(9):1411-6. PubMed ID: 24947059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
